Sign In
Buy PCRX
$26.41
-0.560 (-2.08%)
At Close: Jul 31, 2026
Goldman Sachs Group Inc. Acquires 27,913 Shares of Pacira Biosciences Inc (NASDAQ:PCRX)
10:12am, Friday, 03'rd Apr 2020
Goldman Sachs Group Inc. raised its position in shares of Pacira Biosciences Inc (NASDAQ:PCRX) by 9.3% in the fourth quarter, according to the company in its most recent filing with the Securities & E
RBC Capital Maintains a Hold Rating on Endo International (ENDP)
05:33pm, Thursday, 02'nd Apr 2020
RBC Capital analyst Randall Stanicky maintained a Hold rating on Endo International (ENDP) today and set a price target of $6.00. The company's shares
RBC Capital Maintains a Hold Rating on Endo International (ENDP)
05:33pm, Thursday, 02'nd Apr 2020
RBC Capital analyst
Randall Stanicky
maintained a
Hold
rating on Endo International (
ENDP
–
Research Report
) today and set a price target of
$6.00
. The company’s shares closed last Thursday at
Stifel Nicolaus Sticks to Its Buy Rating for Principia Biopharma (PRNB)
08:51am, Thursday, 02'nd Apr 2020
In a report issued on March 29, Derek Archila from Stifel Nicolaus reiterated a Buy rating on Principia Biopharma (PRNB), with a price target of $76.00.
Stifel Nicolaus Sticks to Its Buy Rating for Principia Biopharma (PRNB)
08:51am, Thursday, 02'nd Apr 2020
In a report issued on March 29,
Derek Archila
from Stifel Nicolaus reiterated a
Buy
rating on Principia Biopharma (
PRNB
–
Research Report
), with a price target of
$76.00
. The company’s shares c
RBC Capital Remains a Hold on Teva Pharmaceutical Industries (TEVA)
01:43pm, Wednesday, 01'st Apr 2020
RBC Capital analyst Randall Stanicky maintained a Hold rating on Teva Pharmaceutical Industries (TEVA) today and set a price target of $11.00. The
Merck & Company (MRK) Gets a Hold Rating from RBC Capital
01:42pm, Wednesday, 01'st Apr 2020
RBC Capital analyst Randall Stanicky maintained a Hold rating on Merck & Company (MRK) today and set a price target of $89.00. The company's shares
Merck & Company (MRK) Gets a Hold Rating from RBC Capital
01:42pm, Wednesday, 01'st Apr 2020
RBC Capital analyst
Randall Stanicky
maintained a
Hold
rating on Merck & Company (
MRK
–
Research Report
) today and set a price target of
$89.00
. The company’s shares closed last Monday at $76.9
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Danaher (DHR), Amneal Pharmaceuticals (AMRX) and CytomX
Envestnet Asset Management Inc. Makes New Investment in Pacira Biosciences Inc (NASDAQ:PCRX)
10:42am, Tuesday, 31'st Mar 2020
Envestnet Asset Management Inc. purchased a new position in shares of Pacira Biosciences Inc (NASDAQ:PCRX) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Co
Stifel Nicolaus Sticks to Their Hold Rating for Amarin (AMRN)
02:58am, Tuesday, 31'st Mar 2020
In a report released yesterday, Derek Archila from Stifel Nicolaus maintained a Hold rating on Amarin (AMRN), with a price target of $8.00. The company's
RBC Capital Maintains a Buy Rating on Perrigo Company (PRGO)
02:33am, Monday, 30'th Mar 2020
In a report issued on March 27, Randall Stanicky from RBC Capital maintained a Buy rating on Perrigo Company (PRGO), with a price target of $58.00. The
RBC Capital Maintains a Buy Rating on Perrigo Company (PRGO)
02:32am, Monday, 30'th Mar 2020
In a report issued on March 27, Randall Stanicky from RBC Capital maintained a Buy rating on Perrigo Company (PRGO
Zacks Investment Research Downgrades Pacira Biosciences (NASDAQ:PCRX) to Hold
10:40am, Sunday, 29'th Mar 2020
Pacira Biosciences (NASDAQ:PCRX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Friday, Zacks.com reports. They presently h
Traders Buy High Volume of Pacira Biosciences Call Options (NASDAQ:PCRX)
05:46am, Saturday, 28'th Mar 2020
Pacira Biosciences Inc (NASDAQ:PCRX) was the recipient of some unusual options trading activity on Friday. Stock investors bought 4,061 call options on the stock. This is an increase of 1,931% compare
